What constitutes a very good partial response in multiple myeloma?

FAQ Library published on March 6, 2013 in Response Assessment, General Education
Download Transcript Download Audio
Rafael Fonseca, MD
Deputy Director, Mayo Clinic Cancer Center
Getz Family Professor of Cancer
Professor of Medicine, Mayo Clinic College of Medicine
Site Director, Hematological Malignancies, Mayo Clinic
Scottsdale, Arizona

Hello, Rafael Fonseca from the Mayo Clinic in Arizona. I am frequently asked what constitutes a very good partial response in the International Myeloma Working Group response criteria. Now these are patients who have serum and urine M-protein that is still detectable by immunofixation but not on electrophoresis, or that they had a 90% or greater reduction in their serum M-spike, plus a urine monoclonal protein that is less than 100 mg per 24 hours. The importance of this response category is that these are patients who achieved very deep responses to therapy, we would consider them with successful treatment yet still have some residual markers that identify their myeloma symptoms.

Reviewed on January 17, 2017 for clinical relevance.

Last modified: February 8, 2017
Related Items by Category
How can you ensure patients are reporting side effects?
FAQ Library published on May 9, 2013 in Response Assessment, Comorbidities/SEs
What is 'stable disease' in multiple myeloma?
FAQ Library published on March 6, 2013 in Response Assessment, General Education
What is the difference between complete response and stringent complete response?
FAQ Library published on March 4, 2013 in Response Assessment, General Education
When do I refer a relapsed/refractory patient to a clinical trial?
FAQ Library published on February 9, 2012 in General Education, Patient Communication, Nurses & Pharmacists, Clinical Trials
What are effective ways to ensure patient compliance?
FAQ Library published on April 20, 2011 in General Education, Patient Communication, Patient Education, Nurses & Pharmacists
Is there a role for multidisciplinary care in the treatment of multiple myeloma?
FAQ Library published on December 9, 2009 in General Education
What is the important endpoint to look for in multiple myeloma studies?
FAQ Library published on July 22, 2009 in Response Assessment
Related Items by Author
What is 'stable disease' in multiple myeloma?
Rafael Fonseca, MD
FAQ Library published on March 6, 2013 in Response Assessment, General Education
What is the difference between complete response and stringent complete response?
Rafael Fonseca, MD
FAQ Library published on March 4, 2013 in Response Assessment, General Education